Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GW870086X for Allergen-induced Asthmatic Response
NCT00857857Phase 2Completed
- Sponsor
- GSK
- Start
- Feb 2009
- Primary completion
- Nov 2009
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of GW870086 in asthma, sponsored by GSK. Started Feb 2009; status: completed.
02
Drugs
GW870086
03
Conditions
asthma
Beyond the preview
Go deeper on NCT00857857.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00857857.